Literature DB >> 412532

An unusual case of a plasma cell neoplasm with an IgG3lambda myeloma and a gamma3 heavy chain disease protein.

J B Adlersberg, V Grann, D Zucker-Franklin, B Frangione, E C Franklin.   

Abstract

A unique case of gamma3 heavy chain disease with two related serum proteins is reported. One molecule appears to be an IgG3lambda myeloma protein. The second molecule is a dimer of a shortened gamma3 heavy chain that has an unblocked amino terminus and lacks the VH and CH1 domains. Its probable origin as a synthetic product is discussed. The clinical and pathologic features of this patient resemble those of other patients with gamma heavy chain disease more than those of patients with multiple myeloma. It seems likely that the heavy chain disease protein is the result of a mutational event in the malignant clone originally producing the myeloma protein.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 412532

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  A case of gamma 3 heavy chain disease with vacuolated plasma cells: a clinical, immunological, and ultrastructural study.

Authors:  W Feremans; M Caudron; C Bieva
Journal:  J Clin Pathol       Date:  1979-04       Impact factor: 3.411

2.  Immunoglobulin heavy-chain-associated amyloidosis.

Authors:  M Eulitz; D T Weiss; A Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Immunochemical and ultrastructural study of multiple myeloma with a heavy chain protein in the serum.

Authors:  C Bartoloni; G Flamini; N Gentiloni; M A Russo; C Barone; G Gambassi; T Terranova
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

4.  Celluar immunoglobulins in human gamma- and alpha-heavy chain diseases.

Authors:  J L Preud'homme; J C Brouet; M Seligmann
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

5.  Gamma heavy chain disease in man. Genomic sequence reveals two noncontiguous deletions in a single gene.

Authors:  A Alexander; I Anicito; J Buxbaum
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

6.  G1 heavy chain disease: clinicopathological, ultrastructural and immunochemical study of a new case.

Authors:  A Stramignoni; A Carbonara; W Paolino; R Navone; R Coda; E Leonardo
Journal:  J Cancer Res Clin Oncol       Date:  1980-01       Impact factor: 4.553

7.  Gamma heavy chain disease in man: synthesis of a deleted gamma3 immunoglobulin by lymphoid cells in short and long term tissue culture.

Authors:  J N Buxbaum; A Alexander; O Olivier
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

8.  gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model.

Authors:  A Alexander; M Steinmetz; D Barritault; B Frangione; E C Franklin; L Hood; J N Buxbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  Deleted IgG1 and IgG2 H chains in a patient with an IgG subclass imbalance.

Authors:  J P Lebreton; M Fontaine; J Rousseaux; P Youinou; D Hurez; L Rivat-Peran; J P Bernards
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.